JP2023078367A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2023078367A5 JP2023078367A5 JP2023045498A JP2023045498A JP2023078367A5 JP 2023078367 A5 JP2023078367 A5 JP 2023078367A5 JP 2023045498 A JP2023045498 A JP 2023045498A JP 2023045498 A JP2023045498 A JP 2023045498A JP 2023078367 A5 JP2023078367 A5 JP 2023078367A5
- Authority
- JP
- Japan
- Prior art keywords
- peptide
- integer
- formula
- group
- item
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2026014743A JP2026075626A (ja) | 2018-04-05 | 2026-01-30 | 新規glp-1類似体 |
Applications Claiming Priority (8)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN201821013109 | 2018-04-05 | ||
| IN201821013109 | 2018-04-05 | ||
| IN201821040468 | 2018-10-26 | ||
| IN201821040468 | 2018-10-26 | ||
| IN201821040474 | 2018-10-26 | ||
| IN201821040474 | 2018-10-26 | ||
| JP2020553627A JP7250814B2 (ja) | 2018-04-05 | 2019-04-05 | 新規glp-1類似体 |
| PCT/IB2019/052835 WO2019193576A1 (en) | 2018-04-05 | 2019-04-05 | Novel glp-1 analogues |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020553627A Division JP7250814B2 (ja) | 2018-04-05 | 2019-04-05 | 新規glp-1類似体 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2026014743A Division JP2026075626A (ja) | 2018-04-05 | 2026-01-30 | 新規glp-1類似体 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023078367A JP2023078367A (ja) | 2023-06-06 |
| JP2023078367A5 true JP2023078367A5 (cg-RX-API-DMAC7.html) | 2023-10-19 |
| JP7863526B2 JP7863526B2 (ja) | 2026-05-21 |
Family
ID=66589592
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020553627A Active JP7250814B2 (ja) | 2018-04-05 | 2019-04-05 | 新規glp-1類似体 |
| JP2023045498A Active JP7863526B2 (ja) | 2018-04-05 | 2023-03-22 | 新規glp-1類似体 |
| JP2026014743A Pending JP2026075626A (ja) | 2018-04-05 | 2026-01-30 | 新規glp-1類似体 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020553627A Active JP7250814B2 (ja) | 2018-04-05 | 2019-04-05 | 新規glp-1類似体 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2026014743A Pending JP2026075626A (ja) | 2018-04-05 | 2026-01-30 | 新規glp-1類似体 |
Country Status (33)
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SMT202200352T1 (it) * | 2018-04-05 | 2022-09-14 | Sun Pharmaceutical Ind Ltd | Analoghi del glp-1 innovativi |
| TWI829687B (zh) | 2018-05-07 | 2024-01-21 | 丹麥商諾佛 儂迪克股份有限公司 | 包含glp-1促效劑與n-(8-(2-羥基苯甲醯基)胺基)辛酸之鹽的固體組成物 |
| WO2020180534A1 (en) | 2019-03-01 | 2020-09-10 | President And Fellows Of Harvard College | Methods and compositions for protein delivery |
| TW202216746A (zh) * | 2020-06-22 | 2022-05-01 | 印度商太陽製藥工業有限公司 | 長效型glp-1/gip雙重促效劑 |
| CN116171164A (zh) * | 2020-10-17 | 2023-05-26 | 太阳医药工业有限公司 | Glp-1/gip双重激动剂 |
| CN114685646B (zh) * | 2020-12-31 | 2023-04-07 | 厦门赛诺邦格生物科技股份有限公司 | 一种多肽侧链类似物的制备方法及其应用 |
| KR20240118914A (ko) | 2021-01-20 | 2024-08-05 | 바이킹 테라퓨틱스 인코포레이티드 | 대사 및 간 질환 치료를 위한 조성물 및 방법 |
| CA3231953A1 (en) | 2021-09-15 | 2023-03-23 | Brian Lian | Compositions and methods for the treatment of metabolic and liver disorders |
| CA3237751A1 (en) | 2021-11-10 | 2023-05-19 | Tyler Brown | Ionic liquid compositions |
| CN115785249B (zh) * | 2022-10-13 | 2023-07-21 | 江苏师范大学 | 一类glp-1类似物及其应用 |
| EP4724472A2 (en) | 2023-06-09 | 2026-04-15 | Sun Pharmaceutical Industries Limited | Glp-1/gip dual, glp-1/gcg dual and glp-1/gip/gcg triple receptor agonists |
| WO2024261580A1 (en) | 2023-06-20 | 2024-12-26 | Sun Pharmaceutical Industries Limited | Glp-1 analog for use in the treatment of metabolic disorders |
| CN117756914B (zh) * | 2023-12-15 | 2024-09-03 | 瀚晖制药有限公司 | 依柯胰岛素的制备方法 |
| AU2025216394A1 (en) | 2024-01-31 | 2026-07-16 | Sun Pharmaceutical Industries Ltd. | High level production of glp1 analogues |
Family Cites Families (58)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6849708B1 (en) | 1986-05-05 | 2005-02-01 | The General Hospital Corporation | Insulinotropic hormone and uses thereof |
| DE122009000079I2 (de) | 1996-08-30 | 2011-06-16 | Novo Nordisk As Novo Alle | Glp-1 derivate |
| US6268343B1 (en) | 1996-08-30 | 2001-07-31 | Novo Nordisk A/S | Derivatives of GLP-1 analogs |
| JP2002508162A (ja) | 1998-02-27 | 2002-03-19 | ノボ ノルディスク アクティーゼルスカブ | N末端を短縮したglp−1誘導体 |
| AU2610899A (en) | 1998-02-27 | 1999-09-15 | Novo Nordisk A/S | N-terminally modified glp-1 derivatives |
| AU3247799A (en) | 1998-02-27 | 1999-09-15 | Novo Nordisk A/S | Glp-1 derivatives of glp-1 and exendin with protracted profile of action |
| EP1060191B1 (en) | 1998-02-27 | 2010-04-28 | Novo Nordisk A/S | Derivatives of glp-1 analogs |
| FR2777283B1 (fr) | 1998-04-10 | 2000-11-24 | Adir | Nouveaux composes peptidiques analogues du glucagon-peptide- 1 (7-37), leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| EP1137667B1 (en) | 1998-12-07 | 2004-11-17 | Societe De Conseils De Recherches Et D'applications Scientifiques S.A.S. | Analogues of glp-1 |
| DE60137876D1 (de) | 2000-06-16 | 2009-04-16 | Lilly Co Eli | Analoge des Glucagon-ähnlichen Peptids-1 |
| SI1724284T1 (sl) | 2000-12-07 | 2009-12-31 | Lilly Co Eli | Glp-1 fuzijski proteini |
| AR038102A1 (es) | 2002-01-08 | 2004-12-29 | Lilly Co Eli | Analogos extendidos de peptido 1 de tipo glucagon |
| WO2004037859A1 (ja) | 2002-10-11 | 2004-05-06 | Sanwa Kagaku Kenkyusho Co., Ltd. | Glp-1誘導体及びその経粘膜吸収型製剤 |
| WO2004078777A2 (en) | 2003-03-04 | 2004-09-16 | Biorexis Pharmaceutical Corporation | Dipeptidyl-peptidase protected proteins |
| EP1633384B1 (en) | 2003-05-15 | 2012-03-14 | Trustees Of Tufts College | Stable analogs of glp-1 |
| EP1670515A2 (en) | 2003-09-19 | 2006-06-21 | Novo Nordisk A/S | Albumin-binding derivatives of therapeutic peptides |
| EP1711523B1 (en) | 2003-12-16 | 2012-10-10 | Ipsen Pharma | Analogues of glp-1 |
| JP2008515856A (ja) | 2004-10-07 | 2008-05-15 | ノボ ノルディスク アクティーゼルスカブ | 遅延性glp−1化合物 |
| ES2484796T3 (es) * | 2005-03-18 | 2014-08-12 | Novo Nordisk A/S | Compuestos de GLP-1 extendidos |
| TWI362392B (en) * | 2005-03-18 | 2012-04-21 | Novo Nordisk As | Acylated glp-1 compounds |
| CA2607566A1 (en) | 2005-05-06 | 2006-11-16 | Bayer Pharmaceuticals Corporation | Glucagon-like peptide 1 (glp-1) receptor agonists and their pharmacological methods of use |
| CA2621699A1 (en) | 2005-09-08 | 2007-03-15 | Trustees Of Tufts College | Stabilized glp-1 analogs |
| RS51319B (sr) | 2005-09-22 | 2010-12-31 | Biocompatibles Uk Limited | GLP-l (GLUKAGON-LIKE PEPTID-l) FUZIONI POLIPEPTIDI SA POVEĆANOM OTPORNOSTI NA PEPTIDAZE |
| US20100261637A1 (en) | 2007-09-05 | 2010-10-14 | Novo Nordisk A/S | Peptides derivatized with a-b-c-d- and their therapeutical use |
| WO2009058734A1 (en) | 2007-10-30 | 2009-05-07 | Indiana University Research And Technology Corporation | Compounds exhibiting glucagon antagonist and glp-1 agonist activity |
| US20120329711A1 (en) | 2009-12-16 | 2012-12-27 | Nordisk A/S | Glp-1 receptor agonist compounds with a modified n-terminus |
| WO2011134284A1 (zh) | 2010-04-27 | 2011-11-03 | 浙江贝达药业有限公司 | 胰高血糖素样肽-1类似物及其应用 |
| CN102203130B (zh) | 2010-08-06 | 2014-06-25 | 贝达药业股份有限公司 | Glp-1衍生物及其应用 |
| JP6231386B2 (ja) | 2010-11-09 | 2017-11-15 | ノヴォ ノルディスク アー/エス | リンカーを有する二重アシル化されたglp−1誘導体 |
| AU2012241894B2 (en) | 2011-04-12 | 2015-12-03 | Novo Nordisk A/S | Double-acylated GLP-1 derivatives |
| WO2012150503A2 (en) | 2011-05-03 | 2012-11-08 | Zealand Pharma A/S | Glu-glp-1 dual agonist signaling-selective compounds |
| JP6126097B2 (ja) | 2011-09-06 | 2017-05-10 | ノヴォ ノルディスク アー/エス | Glp−1誘導体 |
| EP2578599A1 (en) | 2011-10-07 | 2013-04-10 | LanthioPep B.V. | Cyclic analogs of GLP-1 and GLP-1 related peptides |
| EP2846823B1 (en) | 2012-05-08 | 2019-12-04 | Novo Nordisk A/S | Double-acylated glp-1 derivatives |
| CN104411322B (zh) | 2012-05-08 | 2017-05-24 | 诺和诺德股份有限公司 | 双酰化glp‑1衍生物 |
| JP2015525226A (ja) | 2012-06-14 | 2015-09-03 | サノフイ | エキセンディン−4ペプチドアナログ |
| UA116217C2 (uk) | 2012-10-09 | 2018-02-26 | Санофі | Пептидна сполука як подвійний агоніст рецепторів glp1-1 та глюкагону |
| TWI617574B (zh) | 2012-12-11 | 2018-03-11 | 梅迪繆思有限公司 | 用於治療肥胖之升糖素與glp-1共促效劑 |
| HUE035803T2 (en) | 2012-12-21 | 2018-05-28 | Sanofi Sa | Dual GLP1 / GIP or trigonal GLP1 / GIP / glucagon agonists |
| AU2014283221A1 (en) | 2013-06-20 | 2015-12-03 | Novo Nordisk A/S | GLP-1 derivatives and uses thereof |
| US9738697B2 (en) | 2013-06-23 | 2017-08-22 | Wisconsin Alumni Research Foundation | Alpha/beta-polypeptide analogs of glucagon-like peptide-1 |
| JP6139712B2 (ja) | 2013-07-04 | 2017-05-31 | ノヴォ ノルディスク アー/エス | Glp−1様ペプチドの誘導体及びその使用 |
| CN105451776B (zh) | 2013-08-15 | 2020-04-17 | 诺和诺德股份有限公司 | Glp-1衍生物及其用途 |
| AR098065A1 (es) * | 2013-10-17 | 2016-04-27 | Zealand Pharma As | Análogos de glucagón acilados |
| TW201609797A (zh) | 2013-12-13 | 2016-03-16 | 賽諾菲公司 | 雙重glp-1/升糖素受體促效劑 |
| WO2015086731A1 (en) | 2013-12-13 | 2015-06-18 | Sanofi | Exendin-4 peptide analogues as dual glp-1/glucagon receptor agonists |
| CA2933405A1 (en) | 2013-12-13 | 2015-06-18 | Medimmune Limited | Protease-resistant peptides |
| JP6730278B2 (ja) | 2014-11-27 | 2020-07-29 | ノヴォ ノルディスク アー/エス | Glp−1誘導体及びその使用 |
| EP3233898A1 (en) | 2014-12-17 | 2017-10-25 | Novo Nordisk A/S | Glp-1 derivatives and uses thereof |
| TWI726889B (zh) | 2015-06-10 | 2021-05-11 | 英商梅迪繆思有限公司 | 蛋白酶抗性之脂化肽 |
| US10111932B2 (en) | 2015-08-26 | 2018-10-30 | Syracuse University | Coagonists of glucagon-like peptide 1 receptor and neuropeptide Y2 receptor |
| WO2017149070A1 (en) | 2016-03-03 | 2017-09-08 | Novo Nordisk A/S | Glp-1 derivatives and uses thereof |
| CA3025592A1 (en) | 2016-06-09 | 2017-12-14 | Medimmune Limited | Protease-resistant mono-lipidated peptides |
| ES2828526T3 (es) | 2016-11-07 | 2021-05-26 | Novo Nordisk As | Esteres activos DCHBS de compuestos PEG y sus usos |
| AR110301A1 (es) | 2016-12-02 | 2019-03-13 | Sanofi Sa | Compuestos como agonistas peptídicos de receptores de glp1 / glucagón / gip |
| WO2018178796A1 (en) * | 2017-03-27 | 2018-10-04 | Sun Pharmaceutical Industries Limited | Method for making kex1 protease sensitive polypeptides using yeast strain |
| PL3704143T3 (pl) | 2018-03-09 | 2024-04-15 | Fresenius Kabi Ipsum S.R.L. | Chemo-enzymatyczna synteza liraglutydu, semaglutydu i glp-1 |
| SMT202200352T1 (it) * | 2018-04-05 | 2022-09-14 | Sun Pharmaceutical Ind Ltd | Analoghi del glp-1 innovativi |
-
2019
- 2019-04-05 SM SM20220352T patent/SMT202200352T1/it unknown
- 2019-04-05 MY MYPI2020004864A patent/MY202560A/en unknown
- 2019-04-05 HU HUE22177403A patent/HUE067499T2/hu unknown
- 2019-04-05 HU HUE19724915A patent/HUE060135T2/hu unknown
- 2019-04-05 PT PT221774037T patent/PT4122954T/pt unknown
- 2019-04-05 PL PL19724915.4T patent/PL3774862T3/pl unknown
- 2019-04-05 CN CN201980037166.1A patent/CN112236444B/zh active Active
- 2019-04-05 SI SI201930764T patent/SI4122954T1/sl unknown
- 2019-04-05 KR KR1020207031696A patent/KR102801994B1/ko active Active
- 2019-04-05 SG SG11202009467YA patent/SG11202009467YA/en unknown
- 2019-04-05 EP EP26164773.9A patent/EP4740955A3/en active Pending
- 2019-04-05 WO PCT/IB2019/052835 patent/WO2019193576A1/en not_active Ceased
- 2019-04-05 EP EP22177403.7A patent/EP4122954B1/en active Active
- 2019-04-05 HR HRP20240749TT patent/HRP20240749T1/hr unknown
- 2019-04-05 IL IL277483A patent/IL277483B2/en unknown
- 2019-04-05 HR HRP20221054TT patent/HRP20221054T1/hr unknown
- 2019-04-05 CN CN202311777728.0A patent/CN117964735A/zh active Pending
- 2019-04-05 FI FIEP24161843.8T patent/FI4364751T3/fi active
- 2019-04-05 LT LTEP24161843.8T patent/LT4364751T/lt unknown
- 2019-04-05 UA UAA202006178A patent/UA128210C2/uk unknown
- 2019-04-05 ES ES19724915T patent/ES2925678T3/es active Active
- 2019-04-05 AU AU2019247936A patent/AU2019247936C1/en active Active
- 2019-04-05 JP JP2020553627A patent/JP7250814B2/ja active Active
- 2019-04-05 LT LTEP22177403.7T patent/LT4122954T/lt unknown
- 2019-04-05 CA CA3095988A patent/CA3095988A1/en active Pending
- 2019-04-05 CN CN202510743440.4A patent/CN120554480A/zh active Pending
- 2019-04-05 MX MX2020010505A patent/MX2020010505A/es unknown
- 2019-04-05 PE PE2020001535A patent/PE20211417A1/es unknown
- 2019-04-05 DK DK22177403.7T patent/DK4122954T3/da active
- 2019-04-05 FI FIEP22177403.7T patent/FI4122954T3/fi active
- 2019-04-05 US US16/376,190 patent/US11447535B2/en active Active
- 2019-04-05 PT PT197249154T patent/PT3774862T/pt unknown
- 2019-04-05 SI SI201930322T patent/SI3774862T1/sl unknown
- 2019-04-05 SM SM20240241T patent/SMT202400241T1/it unknown
- 2019-04-05 EP EP24161843.8A patent/EP4364751B1/en active Active
- 2019-04-05 PL PL22177403.7T patent/PL4122954T3/pl unknown
- 2019-04-05 RS RS20240706A patent/RS65639B1/sr unknown
- 2019-04-05 EP EP19724915.4A patent/EP3774862B1/en active Active
- 2019-04-05 RS RS20220814A patent/RS63523B1/sr unknown
- 2019-04-05 BR BR112020020419-6A patent/BR112020020419A2/pt unknown
- 2019-04-05 KR KR1020257013603A patent/KR102990055B1/ko active Active
- 2019-04-05 DK DK19724915.4T patent/DK3774862T3/da active
- 2019-04-05 LT LTEPPCT/IB2019/052835T patent/LT3774862T/lt unknown
- 2019-04-05 DK DK24161843.8T patent/DK4364751T3/da active
- 2019-04-05 ES ES22177403T patent/ES2980707T3/es active Active
-
2020
- 2020-08-04 US US16/985,207 patent/US11242373B2/en active Active
- 2020-09-29 PH PH12020551591A patent/PH12020551591A1/en unknown
- 2020-10-02 CO CONC2020/0012425A patent/CO2020012425A2/es unknown
- 2020-10-04 JO JOJO/P/2020/0251A patent/JOP20200251B1/ar active
- 2020-10-05 CL CL2020002574A patent/CL2020002574A1/es unknown
- 2020-10-05 MX MX2024007688A patent/MX2024007688A/es unknown
- 2020-11-05 EC ECSENADI202070185A patent/ECSP20070185A/es unknown
- 2020-12-28 US US17/134,982 patent/US11485766B2/en active Active
-
2022
- 2022-08-01 US US17/816,577 patent/US11873328B2/en active Active
- 2022-08-12 US US17/819,466 patent/US11866477B2/en active Active
- 2022-09-06 CY CY20221100590T patent/CY1125528T1/el unknown
-
2023
- 2023-03-22 JP JP2023045498A patent/JP7863526B2/ja active Active
- 2023-06-01 AU AU2023203430A patent/AU2023203430B2/en active Active
- 2023-06-30 ZA ZA2023/06729A patent/ZA202306729B/en unknown
- 2023-11-21 US US18/515,712 patent/US12421289B2/en active Active
-
2024
- 2024-05-17 US US18/667,531 patent/US20240376175A1/en active Pending
-
2025
- 2025-10-02 AU AU2025242190A patent/AU2025242190A1/en active Pending
-
2026
- 2026-01-30 JP JP2026014743A patent/JP2026075626A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7658877B2 (ja) | インクレチン類似体およびその使用 | |
| FI72981C (fi) | Foerfarande foer framstaellning av terapeutiskt anvaendbara polypeptider. | |
| RU2485135C2 (ru) | Соединения оксинтомодулина (варианты), фармацевтическая композиция на их основе, способы лечения и профилактики ожирения и сопутствующих заболеваний (варианты) и лекарственное средство (варианты) | |
| PE20231841A1 (es) | Coagonistas de los receptores glp-1 y gip adecuados para el suministro oral | |
| HRP20221054T1 (hr) | Novi analozi glp-1 | |
| PT1143989E (pt) | Exendinas para supressão de glucagon | |
| JP2004514651A (ja) | グレリン類似体 | |
| JP2000143613A (ja) | 成長ホルモン放出特性を有する化合物 | |
| JPH06340691A (ja) | ペプチド類 | |
| FR2677361A1 (fr) | Nouveaux peptides et pseudopeptides, derives de tachykinines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. | |
| CN110099692A (zh) | 作为神经肽y受体调节剂的环状肽酪氨酸酪氨酸化合物 | |
| WO2013029279A1 (zh) | 新的glp-ⅰ类似物及其制备方法和用途 | |
| JP2007518818A5 (cg-RX-API-DMAC7.html) | ||
| JP2012512903A5 (cg-RX-API-DMAC7.html) | ||
| KR19990028303A (ko) | 성장호르몬 방출 특성을 가지는 화합물 | |
| JP2023071869A (ja) | グルカゴンおよびglp-1受容体の長時間作用型コアゴニスト | |
| JPH06503090A (ja) | ノナペプチドのボンベシン拮抗薬 | |
| JP2022543826A5 (cg-RX-API-DMAC7.html) | ||
| CA2385659A1 (en) | Novel antiarrhythmic peptides | |
| JP2009507847A (ja) | 生体利用性を増強したt3及びt4のプロドラッグ | |
| JP2781782B2 (ja) | 新規ペプチド | |
| HUT75538A (en) | Oligopeptides derived from c-reactive protein fragments | |
| JPH11510147A (ja) | 成長ホルモンに対する阻害活性をもつソマトスタチン類似環状ペプチド | |
| US6211145B1 (en) | Bicyclic depsipeptides | |
| JP7218906B2 (ja) | 血管機能の検出方法、高血圧症の進行段階を判定する方法、高血圧症の進行段階を判定するためのキット及び高血圧症の治療効果の予測方法 |